Cargando…

Early-Onset Neutropenia Induced by Rituximab in a Patient with Lupus Nephritis and Hemolytic Anemia

Rituximab is an anti-CD20 monoclonal antibody that has been used to treat several complications of systemic lupus erythematosus (SLE) including nephritis, cerebritis, and hematological disorders. Neutropenia is among the adverse events associated with rituximab; this usually occurs several weeks aft...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arroyo-Ávila, Mariangelí, Fred-Jiménez, Ruth M., Vilá, Luis M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342062/ https://www.ncbi.nlm.nih.gov/pubmed/25767732 http://dx.doi.org/10.1155/2015/616787

Ejemplares similares

Rituximab for treatment of severe lupus nephritis
por: Baskin, E, et al.
Publicado: (2008)

Cold autoimmune hemolytic anemia resolved by rituximab
por: Palombi, Massimiliano, et al.
Publicado: (2010)

Clinical Manifestations Associated with Overweight/Obesity in Puerto Ricans with Fibromyalgia Syndrome
por: Fred-Jiménez, Ruth M., et al.
Publicado: (2016)

Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Clinical efficacy and safety of rituximab in lupus nephritis
por: Zhong, Zhiqing, et al.
Publicado: (2019)

Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia
por: Murakhovskaya, Irina
Publicado: (2020)

Anemia in lupus nephritis; etiological profile
por: Ardalan, Mohammad-Reza
Publicado: (2013)

Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus
por: Vázquez-Otero, Ileana, et al.
Publicado: (2020)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Long-Term Outcomes in Puerto Ricans with Rheumatoid Arthritis (RA) Receiving Early Treatment with Disease-Modifying Anti-Rheumatic Drugs using the American College of Rheumatology Definition of Early RA
por: Varela-Rosario, Noemí, et al.
Publicado: (2017)

Concomitant acute interstitial nephritis and autoimmune hemolytic anemia induced by omeprazole
por: Sharma, Neetu, et al.
Publicado: (2020)

Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab
por: Aftab, Adan, et al.
Publicado: (2022)

Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE
por: Gilbert, Mileka, et al.
Publicado: (2021)

Late-Onset Neutropenia after Rituximab Treatment for Adult-Onset Nephrotic Syndrome
por: Yamazaki, Mayuko, et al.
Publicado: (2019)

Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas
por: Fozza, Claudio, et al.
Publicado: (2011)

Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab
por: Raufi, Alexander G., et al.
Publicado: (2016)

Neuropsychiatric Lupus and Lupus Nephritis Successfully Treated with Combined IVIG and Rituximab: An Alternative to Standard of Care
por: Cheikh, Mohamed M., et al.
Publicado: (2022)

Early Onset Neutropenia due to Rituximab Therapy in Mantle Cell Lymphoma: A Case Report
por: Nelson, Blessie Elizabeth, et al.
Publicado: (2021)

Unusual manifestations of acute Q fever: autoimmune hemolytic anemia and tubulointerstitial nephritis
por: Korkmaz, Serdal, et al.
Publicado: (2012)

Rituximab is effective in the treatment of nephritis in lupus patients, refractory to conventional immunosuppressive therapy
por: Martínez, R, et al.
Publicado: (2010)

Erythrodermic Psoriasis after Rituximab Treatment in a Patient with Autoimmune Hemolytic Anemia
por: Koumaki, Dimitra, et al.
Publicado: (2021)

Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
por: Yao, Mingkang, et al.
Publicado: (2022)

Late-Onset Systemic Lupus Erythematosus Associated with Autoimmune Hemolytic Anemia and Sixth Cranial Nerve Palsy
por: Kuroda, Kaku, et al.
Publicado: (2021)

Incident arterial vascular events in a cohort of Puerto Ricans with rheumatoid arthritis
por: González-Meléndez, Ariana, et al.
Publicado: (2020)

The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
por: Tesfa, Daniel, et al.
Publicado: (2021)

Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study
por: Chavarot, Nathalie, et al.
Publicado: (2017)

Efficacy and safety of rituximab in autoimmune and microangiopathic hemolytic anemia: a systematic review and meta-analysis
por: Chao, Shih-Hsuan, et al.
Publicado: (2020)

Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy
por: Tanaka, Yoshiya, et al.
Publicado: (2016)

Effective use of rituximab in combination with low dose cyclophosphamide in childhood onset systemic lupus erythematosus (SLE) with relapsing class IV nephritis
por: Miettunen, PM, et al.
Publicado: (2008)

Rituximab therapy for juvenile-onset systemic lupus erythematosus
por: Nwobi, Obioma, et al.
Publicado: (2007)

Fetal and maternal outcome in patients with active lupus nephritis: comparison between new-onset and pre-existing lupus nephritis
por: Lian, Xing-Ji, et al.
Publicado: (2021)

Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis
por: Atisha‐Fregoso, Yemil, et al.
Publicado: (2020)

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
por: Salmon, J H, et al.
Publicado: (2015)

Severe Acute Interstitial Nephritis, Dermatitis, and Hemolytic Anemia due to Polyparasitic Infection in an Immunocompetent Male Patient
por: Mrabet, Sanda, et al.
Publicado: (2022)

Systemic lupus erythematosus, hypoparathyroidism, and hemolytic anemia in a patient with Wilson’s disease
por: Mageed, Sarah Abdel, et al.
Publicado: (2019)

49 Autoimmune hemolytic anemia revealing a familial systemic lupus erythematosus
por: Hatem, Rouag, et al.
Publicado: (2022)

Rituximab-Related Late-Onset Neutropenia in Patients with Rheumatic Diseases: Successful Re-Challenge of the Treatment
por: Reitblat, Tatiana, et al.
Publicado: (2015)

A case of late-onset neutropenia secondary to rituximab in a patient with mucous membrane pemphigoid
por: Schultz, Brittney, et al.
Publicado: (2019)

Rituximab therapy in a patient with autoimmune hemolytic anemia and immune thrombocytopenia associated with chronic lymphocytic leukemia
por: Aleem, Aamer
Publicado: (2008)

Successful Treatment of a Korean Infant with Giant Cell Hepatitis with Autoimmune Hemolytic Anemia Using Rituximab
por: Kim, Young Ho, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_koani2irekkphla6l6jknh5dl4